These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 7583048)

  • 21. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
    Schwartz MM; Sharon Z; Pauli BU; Lewis EJ
    Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats.
    Inkster ME; Cotter MA; Cameron NE
    Eur J Pharmacol; 2007 Apr; 561(1-3):63-71. PubMed ID: 17291486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
    Diamond JR; Karnovsky MJ
    J Lab Clin Med; 1987 May; 109(5):538-44. PubMed ID: 3572200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
    J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside.
    Hoyer JR; Mauer SM; Michael AF
    J Lab Clin Med; 1975 May; 85(5):756-68. PubMed ID: 1091713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A scanning and transmission electron microscopic comparison of puromycin aminonucleoside-induced nephrosis to hyperalbuminemia-induced proteinuria with emphasis on kidney podocyte pedicel loss.
    Andrews PM
    Lab Invest; 1977 Feb; 36(2):183-97. PubMed ID: 839733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of aminonucleoside, daunomycin, and adriamycin on carbon oxidation by glomeruli.
    Kaplan BS; Renaud L; Drummond KN
    Lab Invest; 1976 Feb; 34(2):174-8. PubMed ID: 1249918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in the glomerulus in aminonucleoside nephrosis in analbuminemic rats.
    Abe H; Shibuya T; Odashima S; Arichi S; Nagase S
    Nephron; 1988; 50(4):351-5. PubMed ID: 3237275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Podocytic cytoskeletal disaggregation and basement-membrane detachment in puromycin aminonucleoside nephrosis.
    Whiteside CI; Cameron R; Munk S; Levy J
    Am J Pathol; 1993 May; 142(5):1641-53. PubMed ID: 8494056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats.
    Radin MJ; Wilke WL; Fettman MJ
    Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):279-82. PubMed ID: 3538253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of xanthine oxidase and xanthine dehydrogenase in skin ischemia.
    Rees R; Smith D; Li TD; Cashmer B; Garner W; Punch J; Smith DJ
    J Surg Res; 1994 Feb; 56(2):162-7. PubMed ID: 8121173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of human Cu, Zn-superoxide dismutase in aminonucleoside nephrosis--evaluation of the morphology and glomerular basement membrane anionic charge sites].
    Higuchi A
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):767-75. PubMed ID: 2273594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
    Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
    Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further evidence for the role of free radicals in the limb teratogenicity of L-NAME.
    Fantel AG; Person RE
    Teratology; 2002 Jul; 66(1):24-32. PubMed ID: 12115777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sialic acid supplementation ameliorates puromycin aminonucleoside nephrosis in rats.
    Pawluczyk IZ; Najafabadi MG; Brown JR; Bevington A; Topham PS
    Lab Invest; 2015 Sep; 95(9):1019-28. PubMed ID: 26121320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Key molecular events in puromycin aminonucleoside nephrosis rats.
    Guan N; Ding J; Deng J; Zhang J; Yang J
    Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats.
    Kawamorita Y; Shiraishi T; Tamura Y; Kumagai T; Shibata S; Fujigaki Y; Hosoyamada M; Nakagawa T; Uchida S
    Physiol Rep; 2017 Aug; 5(15):. PubMed ID: 28774949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course of lipid peroxidation in puromycin aminonucleoside-induced nephropathy.
    Fawcett JP; Jiang R; Walker RJ
    Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):227-34. PubMed ID: 7881871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of hepatic xanthine oxidase and xanthine dehydrogenase activities on liver function in chronic cholestasis.
    Schimpl G; Pesendorfer P; Kuesz AM; Ratschek M; Höllwarth ME
    Pediatr Surg Int; 2000; 16(4):297-301. PubMed ID: 10898233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
    Garin EH; Boggs KP; Burke FC
    Int J Pediatr Nephrol; 1985; 6(2):117-20. PubMed ID: 4030221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.